Lunai Bioworks LNAI
NASDAQ LNAI
$0.16 -0.08 (-33.33%)
At close: Oct 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Selling, General & Administrative (2011 - 2026)

Updated

Lunai Bioworks (LNAI) posted Selling, General & Administrative of $2.2 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 45.0% from $4 million a year earlier but up 54.9% from the prior quarter.

Analysis

Lunai Bioworks (LNAI) Selling, General & Administrative (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Lunai Bioworks' Selling, General & Administrative came in at $7.8 million, down 56.4% from FY2025.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 0.6% (FY2021 to FY2026).
  • In prior fiscal years, Lunai Bioworks' Selling, General & Administrative was $17.88 million in FY2025 (-27.2%), $24.56 million in FY2024 (+60.3%), $15.32 million in FY2023 (+6.9%) and $14.33 million in FY2022 (+89.6%).
  • Quarterly Selling, General & Administrative has run from a low of $1.42 million in fiscal Q3 2026 to a high of $8.29 million in fiscal Q1 2024 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last six quarters, with an average decline of 38.2% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q1 2022, with growth of 148.5%; the weakest was fiscal Q3 2026, with a decline of 66.4%.
  • According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $1.42 million (Q3 2026), $1.77 million (Q2 2026) and $2.41 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 6.29 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 4.09 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 5.11 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 3.28 Bn
10 Lunai Bioworks 537,744.47 537,744.47 - 2.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.20 Mn
Mar 31, 2026 1.42 Mn
Dec 31, 2025 1.77 Mn
Sep 30, 2025 2.41 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 4.22 Mn
Dec 31, 2024 4.35 Mn
Sep 30, 2024 5.30 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 7.65 Mn
Dec 31, 2023 3.62 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 2.95 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 4.01 Mn
Sep 30, 2022 4.56 Mn
Jun 30, 2022 3.16 Mn
Mar 31, 2022 2.79 Mn
Dec 31, 2021 3.96 Mn
Sep 30, 2021 4.42 Mn
API Access

Lunai Bioworks Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LNAI&period=max&api_key=YOUR_API_KEY